Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Founded in 2012 by Mike Lynch OBE FREng FRS, Invoke Capital is based in Europe and specializes in investing in and advising technology companies. The firm emphasizes collaboration with its portfolio companies and has a strong focus on artificial intelligence. Invoke Capital's approach is distinct from traditional venture capital, as it selectively invests and supports companies through various growth stages.
Invoke Capital invests in technology companies at pre-seed, seed, Series A, B, and C stages, particularly in AI, cybersecurity, and healthcare. The firm seeks to identify fundamental technologies that offer innovative solutions to market challenges. Investments range from founding stages to public offerings, reflecting a commitment to long-term growth.
Notable companies in Invoke Capital's portfolio include Darktrace, a cybersecurity AI firm with over 1,500 employees; Luminance, a machine learning platform for the legal sector; and Featurespace, which specializes in AI fraud detection. Sophia Genetics is a data-driven medicine company that successfully exited in 2020.
Submit your pitch through their form at invokecapital.com.
Invoke Capital often takes a leading role in funding rounds, particularly when they see strong potential in a technology company.
The firm is open to follow-on investments, especially for companies that demonstrate significant growth and alignment with their investment thesis.
Specific fund size details are not publicly disclosed, but the firm focuses on making selective investments across various stages.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.